After a total knee replacement, osteoporosis increases the risk of revision surgery.

Published Date: 10 Nov 2023

The year 1968 marked the performance of the first knee replacement surgery. Improvements in surgical methods and supplies since then have significantly raised its.

Read Full News

Latest News

FDA Declines to Approve Sobi's Gout Therapy on Concerns Over Manufacturing

The U.S. Food and Drug Administration declined to approve Swedish drugmaker Sobi's therapy to treat uncontrolled ⁠gout, a common form of inflammatory arthritis, the company...

Optimizing the Use of Disease-Modifying Therapies Across the Spinal Muscular Atrophy Care Continuum: An Expert TheraTalk

Optimizing the Use of Disease-Modifying Therapies Across the Spinal Muscular Atrophy Care Continuum: An Expert TheraTalk

ASBMR: American Society for Bone and Mineral Research

AAOS: American Academy of Orthopaedic Surgeons

Doctor Tripped Up by $64,000 Bill for Ankle Surgery and Hospital Stay

An insurance contract quirk leads to a claim denial

Partial vs Total Knee Replacement: Is One Superior?

Photo finish after 10 years in randomized trial, but a winner is identified

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Latest News

The U.S. Food and Drug Administration declined to approve Swedish drugmaker Sobi's therapy to treat uncontrolled ⁠gout, a common form of inflammatory arthritis, the company...

Optimizing the Use of Disease-Modifying Therapies Across the Spinal Muscular Atrophy Care Continuum: An Expert TheraTalk

An insurance contract quirk leads to a claim denial

Photo finish after 10 years in randomized trial, but a winner is identified

News All Time

Arthroplasty Patients Usually Have Other Problems That Affect Post-Op Satisfaction

And this could soon impact surgeons' reimbursements

For Nicotine Users Needing Rotator Cuff Repair, Vapes May Be Better Than Smokes

Study shows fewer postoperative complications

Matching Drug to Bug Is Crucial to Treat Prosthetic Joint Infections

Three studies highlight ways to improve outcomes for vexing problem

In Spine Surgery, Blood Thinners May Hurt More Than They Help

Single-center study finds no thrombosis prevention and more complications

GLP-1 Drugs and Bone Injury; 'Fire-Breathing' Teen Trend; Saunas' Health Benefits?

Health news and commentary gathered by MedPage Today staff

Robotic Hip Arthroplasty: Infection Risk Skyrockets in Morbid Obesity

Technology assistance reduces some complications, but could make infections more likely

Achilles Tendon Ruptures Rare in Pro Soccer, but Devastating When They Happen

Top-level U.S. players typically out 8 months; longer for those 26 or younger

Has Baseball's Pitch Clock Altered Players' Injury Risk?

Starting pitchers suffering UCL tears earlier in the season, study shows

RFK Jr. to Undergo Surgery

HHS secretary out all week, plans to return next Monday, spokesperson tells MedPage Today

Here's What Doctors Should Know About the Stryker Cyberattack

Attack mainly affected ordering; most beds, cardiac devices, surgical products cleared for use

William Shatner's Surgery; 'Brain Dead' Woman Wakes Up; Near-Fatal Measles Case

Health news and commentary gathered by MedPage Today staff

Quiz Time: Why Did RFK Jr. Have Surgery?

You passed medical training, now see if you can pass our weekly quiz

Deadly Pickleball Match; Malone Exits ACIP: 'Last Straw'; Novel Parkinson's Therapy?

Health news and commentary gathered by MedPage Today staff

Trial Breathes New Life Into Neurotrophins as Target in Osteoarthritis

Novel agent outperforms placebo in phase II trial, but is it enough?

Tried-and-True Carpal Tunnel Treatment Flops in Controlled Trial

Splinting no better than a simple "placebo" bandage

He Didn't Know He Broke 11 Ribs. This Surprise Condition Was to Blame.

Case report highlights challenges of tumor-induced osteomalacia

Recommended News For You

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Smart exercise planning could boost recovery for people with cancer

Alternative Medicine for Breast Cancer: Study Raises Concern

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

Recommended Articles For You

Clinical Methods in Hematology and Quality Improvement 

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection 

Gene Therapy for Hemophilia: A New Hope on the Horizon 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inner Thoughts of Leonard Bernstein, the "Maestro".

2.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

3.

No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC

4.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

5.

A promising medication could slow brain tumors in children.

1.

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025

2.

Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies

3.

Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances

4.

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases

5.

Generative AI for Adaptive Oncology Trial Design

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

Current Scenario of Cancer- The Incidence of Cancer in Men

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot